Related Experiment Video

Updated: Jul 16, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Iloprost-induced sudden hearing loss.

E Dursun1, S Dogru, H Cincik

  • 1Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey. drengindursun@yahoo.com

The Journal of Laryngology and Otology
|March 16, 2007
PubMed
Summary

Iloprost, used for Raynaud's phenomenon, may cause sudden hearing loss. This hearing impairment reversed within eight days of stopping the medication, suggesting iloprost ototoxicity.

More Related Videos

Research Application of Laser-Induced Shock Wave for Studying Blast-Induced Cochlear Injury05:44

Research Application of Laser-Induced Shock Wave for Studying Blast-Induced Cochlear Injury

Published on: March 1, 2024

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...